Springworks Therapeutics Inc., of Stamford, Conn., said it closed its IPO of 10.35 million shares of common stock that includes the exercise in full by the underwriters of their option to purchase up to 1.35 million additional shares at $18 each. The gross proceeds were $186.3 million. The company's shares are now listed on Nasdaq under the ticker symbol SWTX.